Skip to main content
Clinical Trials/NCT04902274
NCT04902274
Terminated
Not Applicable

Effectiveness of Transcranial Direct Current Stimulation (tDCS) in Musculoskeletal Rehabilitation.

Keller Army Community Hospital1 site in 1 country41 target enrollmentAugust 19, 2020

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Ankle Sprains
Sponsor
Keller Army Community Hospital
Enrollment
41
Locations
1
Primary Endpoint
Composite Pain Rating
Status
Terminated
Last Updated
4 years ago

Overview

Brief Summary

Reducing pain and recovery of strength and function are major challenges in physical therapy. Transcranial direct current stimulation (tDCS) is a novel intervention that has gained popularity in the rehabilitation of athletic injuries, pain management, and sports performance. Acute application of tDCS has been shown to modulate the perception of effort and fatigue, enhance motor learning, improve endurance performance, and improve muscular power and strength. tDCS has also been shown to reduce pain in patients with chronic pain conditions. Using a double-blind, randomized clinical trial design, we aim to evaluate the effectiveness of tDCS plus standard rehabilitation compared to rehabilitation alone on pain, balance and proprioception, functional performance, and strength following acute ankle inversion sprain. We hypothesize that the group using tDCS will demonstrate superior outcomes in all variables of interest.

Registry
clinicaltrials.gov
Start Date
August 19, 2020
End Date
December 17, 2021
Last Updated
4 years ago
Study Type
Interventional
Study Design
Parallel
Sex
All

Investigators

Responsible Party
Sponsor

Eligibility Criteria

Inclusion Criteria

  • Within 2-weeks s/p acute grade 1 or 2 ankle inversion sprain

Exclusion Criteria

  • Self-Reported Pregnancy
  • Being treated for and on medication for a mental health diagnosis
  • Concussion or non-lateral ankle sprain lower extremity injuries within the past 6 months
  • Open wound or dermatologic lesion on the head or region of application
  • Active implantable medical devices such as cochlear implants or cardiac pacemakers, or with metal implants in the head (excluding standard orthodontic braces, fillings, etc.).
  • Epilepsy or history of seizures
  • Participants who are not fluent in English

Outcomes

Primary Outcomes

Composite Pain Rating

Time Frame: Change from Baseline to 8-weeks

Numerical Pain Rating Scale assessment of Current, Best 24-hour, Worst 24-hour Pain

Secondary Outcomes

  • Self-Reported Function(Change from Baseline to 8-weeks)
  • Muscle Power(Change from Baseline to 8-weeks)
  • Dynamic balance(Change from Baseline to 8-weeks)
  • Proprioception(Change from Baseline to 8-weeks)
  • Muscle Strength(Change from Baseline to 8-weeks)

Study Sites (1)

Loading locations...

Similar Trials